From January 1, 2024 to March 31, 2024, the company has repurchased 102,459 shares, representing 0.01% for CNY 3 million. With this, the company has completed the repurchase of 781,486 shares, representing 0.08% for CNY 29.88 million under the buyback announced on September 10, 2023.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
12.52 HKD | -0.79% | +1.46% | -35.60% |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-35.60% | 3.56B | |
-2.27% | 89.08B | |
+3.55% | 40.9B | |
-14.40% | 32.25B | |
+55.89% | 25.14B | |
-15.96% | 15.39B | |
-15.50% | 11.91B | |
-41.29% | 11.89B | |
-11.75% | 11.64B | |
+7.87% | 9.03B |
- Stock Market
- Equities
- 1877 Stock
- News Shanghai Junshi Biosciences Co., Ltd.
- Tranche Update on Shanghai Junshi Biosciences Co., Ltd.'s Equity Buyback Plan announced on September 10, 2023.